News

The Lung Disease Most Americans Don’t Know They’re at Risk For

For most Americans, the letters "NTM" don’t mean anything. But for tens of thousands of people across the country, they ...

aTyr Pharma: Estimating Their Phase 3 Lung Disease Trial Outcome

In 2021, ATYR completed a phase 1b/2a trial in pulmonary sarcoidosis, and have since started a phase 3 trial. Currently the ...

US FDA approves Insmed's drug as first treatment for a chronic lung disease

The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...

First drug to treat bronchiectasis lung condition approved by FDA

The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under ...

Breakthrough Nanobody Tech Hits Lung Cancer Cells Like a Drone Strike

The A5 nanobody is around 10 times smaller than conventional antibodies, helping it to penetrate deep into tissues. Crucially, it can bind selectively to cancer cells, leading to a reduction of more ...
Medscape1d

Legionnaires’ Disease Hits Hard in Harlem

Legionnaires’ disease is a rare condition, and incidence is hard to estimate because diagnosis requires a suspicion of ...
Atlanta Journal-Constitution4mon

Pope Francis battled chronic lung disease. Here’s what we know about it

The lung disease sometimes causes coughs that produce mucus (sometimes blood), fever, sweating, shaking, rapid breathing, sharp chest pain, loss of appetite, nausea and confusion.